⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATTO News
Attovia Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
ATTO
Attovia Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update
globenewswire.com
ATTO
Attovia Therapeutics Announces Positive Topline 12-Week Results from Phase 1b Study of ATTO-1310 in Patients with Chronic Pruritus and High-Itch Atopic Dermatitis
globenewswire.com
ATTO
Attovia Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
ATTO
Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026
globenewswire.com
ATTO
Attovia Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
ATTO
Form 8-K
sec.gov
ATTO
Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
globenewswire.com
ATTO
FORECLOSURE ACTIVITY REMAINS ELEVATED FROM A YEAR AGO IN JULY 2026
prnewswire.com
ATTO
Form 8-K
sec.gov
ATTO